• 1
    Sanchez-Ortiz RF,Huang WC,Mick R,Van Arsdalen KN,Wein AJ,Malkowicz SB. An interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma. J Urol. 2003; 169: 110115; discussion 115.
  • 2
    Verkooijen HM,Fioretta GM,Rapiti E, et al. Patients' refusal of surgery strongly impairs breast cancer survival. Ann Surg. 2005; 242: 276280.
  • 3
    Chang EY,Glissmeyer M,Tonnes S,Hudson T,Johnson N. Outcomes of breast cancer in patients who use alternative therapies as primary treatment. Am J Surg. 2006; 192: 471473.
  • 4
    Mahmud SM,Fong B,Fahmy N,Tanguay S,Aprikian AG. Effect of preoperative delay on survival in patients with bladder cancer undergoing cystectomy in Quebec: a population based study. J Urol. 2006; 175: 7883; discussion 83.
  • 5
    Chow WH,Devesa SS,Warren JL,Fraumeni JFJr. Rising incidence of renal cell cancer in the United States. JAMA. 1999; 281: 16281631.
  • 6
    Hock LM,Lynch J,Balaji KC. Increasing incidence of all stages of kidney cancer in the last 2 decades in the United States: an analysis of Surveillance, Epidemiology and End Results Program Data. J Urol. 2002; 167: 5760.
  • 7
    Hollingsworth JM,Miller DC,Daignault S,Hollenbeck BK. Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst. 2006; 98: 1331134.
  • 8
    Nguyen MM,Gill IS,Ellison LM. The evolving presentation of renal carcinoma in the United States: trends from the Surveillance, Epidemiology, and End Results Program. J Urol. 2006; 176(6 pt 1): 23972400; discussion 2400.
  • 9
    Kunkle DA,Crispen PL,Li T,Uzzo RG. Tumor size predicts synchronous metastatic renal cell carcinoma: implications for surveillance of small renal masses. J Urol. 2007; 177: 1692166; discussion 197.
  • 10
    Kunkle DA,Egleston BL,Uzzo RG. Excision, ablation, or surveillance of small renal masses: meta-analysis and contemporary literature review. J Urol. In press.
  • 11
    Chawla SN,Crispen PL,Hanlon AL,Greenberg RE,Chen DY,Uzzo RG. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol. 2006; 175: 425431.
  • 12
    Crispen PL,Uzzo RG. Active surveillance of clinically localized sporadic renal cell carcinoma. AUA Update Series. 2006; 25: 118123.
  • 13
    Levy DA,Slaton JW,Swanson DA,Dinney CP. Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinoma. J Urol. 1998; 159: 1163117.
  • 14
    Lane BR,Babineau D,Kattan MW, et al. A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy. J Urol. 2007; 178: 429434.
  • 15
    Jayson M,Sanders H. Increased incidence of serendipitously discovered renal cell carcinoma. Urology. 1998; 51: 203205.
  • 16
    Frank I,Blute ML,Cheville JC,Lohse CM,Weaver AL,Zincke H. Solid renal tumors: an analysis of pathological features related to tumor size. J Urol. 2003; 170(6 pt 1): 22172220.
  • 17
    Katz DL,Zheng T,Holford TR,Flannery J. Time trends in the incidence of renal carcinoma: analysis of Connecticut Tumor Registry data, 1935–1989. Int J Cancer. 1994; 58: 5763.
  • 18
    Hollingsworth JM,Miller DC,Dunn RL, et al. Surgical management of low-stage renal cell carcinoma: technology does not supersede biology. Urology. 2006; 67: 11751180.
  • 19
    Kouba E,Smith A,McRackan D,Wallen EM,Pruthi RS. Watchful waiting for solid renal masses: insight into the natural history and results of delayed intervention. J Urol. 2007; 177: 466470; discussion 470.
  • 20
    Klotz L. Active surveillance for prostate cancer: for whom? J Clin Oncol. 2005; 23: 8165819.
  • 21
    Roberts WW,Bhayani SB,Allaf ME,Chan TY,Kavoussi LR,Jarrett TW. Pathological stage does not alter the prognosis for renal lesions determined to be stage T1 by computerized tomography. J Urol. 2005; 173: 713715.
  • 22
    Hsu RM,Chan DY,Siegelman SS. Small renal cell carcinomas: correlation of size with tumor stage, nuclear grade, and histologic subtype. AJR Am J Roentgenol. 2004; 182: 551557.
  • 23
    Campbell SC,Novick AC,Herts B, et al. Prospective evaluation of fine needle aspiration of small, solid renal masses: accuracy and morbidity. Urology. 1997; 50: 2529.
  • 24
    Richter F,Kasabian NG,Irwin RJJr,Watson RA,Lang EK. Accuracy of diagnosis by guided biopsy of renal mass lesions classified indeterminate by imaging studies. Urology. 2000; 55: 348352.
  • 25
    Wood BJ,Khan MA,McGovern F,Harisinghani M,Hahn PF,Mueller PR. Imaging guided biopsy of renal masses: indications, accuracy and impact on clinical management. J Urol. 1999; 161: 1470144.
  • 26
    Dechet CB,Zincke H,Sebo TJ, et al. Prospective analysis of computerized tomography and needle biopsy with permanent sectioning to determine the nature of solid renal masses in adults. J Urol. 2003; 169: 7174.
  • 27
    Blute ML,Thibault GP,Leibovich BC,Cheville JC,Lohse CM,Zincke H. Multiple ipsilateral renal tumors discovered at planned nephron sparing surgery: importance of tumor histology and risk of metachronous recurrence. J Urol. 2003; 170: 760763.
  • 28
    Siu W,Hafez KS,Johnston WK3rd,Wolf JSJr. Growth rates of renal cell carcinoma and oncocytoma under surveillance are similar. Urol Oncol. 2007; 25: 115119.
  • 29
    Kunkle DA,Crispen PL,Chen DY,Greenberg RE,Uzzo RG. Enhancing renal masses with zero net growth during active surveillance. J Urol. 2007; 177: 849854.
  • 30
    Crispen PL. Predicting growth of solid renal masses under active surveillance. Urol Oncol. In press.